Meriwether Wealth & Planning’s Regeneron Pharmaceuticals REGN Stock Holding History

Meriwether Wealth & Planning’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$23.5K	Buy	+31	New	+$23.4K	0.01%	337

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.22B AUM 4.07% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Meriwether Wealth & Planning's REGN Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 31 shares worth $23.5K. The stake represents 0.01% of the portfolio and ranks #337 among its holdings.

468 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

Meriwether Wealth & Planning held 31 shares of Regeneron Pharmaceuticals worth $23.5K as of Q3 2026.
Regeneron Pharmaceuticals was a new Meriwether Wealth & Planning position in Q3 2026.
Regeneron Pharmaceuticals made up 0.01% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #337 holding.
468 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.